February 2009
Drs. Sanchorawala and Sloan are co-authors in a new book “Myeloma Therapy”, edited by Lonial. Chapter 28: Anemia and Erythropoietic Growth Factors in Multiple Myeloma (Sloan) and Chapter 33: AL Amyloidosis (Sanchorawala).
“Reaccreditation with Commendation of the Cancer Programs by the American College of Surgeons.” For more information, please visit www.acosog.org
Dr. Vaishali Sanchorawala presented a talk at the International Myeloma Working Group Meeting in Washington on, “Improving Care for Patients with Amyloidosis” in the session on, “Future Directions and Strategies in the Evaluation and Treatment of Clonal Plasma Cell Disorders”.
At the annual ASBMT meeting, Kathy Finn, NP presented on, “Clinical Pathways and Standard Operating Procedures: Essential Tools for Outpatient Stem Cell Transplant Programs Treating Patients with AL Amyloidosis.” Michael Rosenzweig, MD presented a poster on “Febrile Reactions Occurring with Second Cycle of High Dose Melphalan and Stem Cell Transplantation in Patients with AL Amyloidosis: A “Melphalan Recall” Reaction”. Dr. Vaishali Sanchorawala delivered and oral presentation on, “Treatment-Related Mortality In Patients With AL Amyloidosis Undergoing High-Dose Melphalan And Stem Cell Transplantation: Trend Over The Past 14 Years At A Single Institution.”